Advanced NanoTherapies
Advanced NanoTherapies develops drug delivery devices for cardiac vascular diseases, offering the SirPlux Duo Drug-Coated Balloon based on proprietary nanoparticle technology for sustained drug release to treat coronary artery disease. The device delivers therapeutic agents directly to arterial walls during angioplasty procedures, utilizing nanoparticle formulations to optimize drug retention and therapeutic…
Funding snapshot
About
Advanced NanoTherapies develops drug delivery devices for cardiac vascular diseases, offering the SirPlux Duo Drug-Coated Balloon based on proprietary nanoparticle technology for sustained drug release to treat coronary artery disease. The device delivers therapeutic agents directly to arterial walls during angioplasty procedures, utilizing nanoparticle formulations to optimize drug retention and therapeutic efficacy. Founded in 2018 and headquartered in Los Gatos, United States, Advanced NanoTherapies has raised approximately $57.4M in Series B funding from investors including Cleveland Clinic, ForMED Ventures, S3 Ventures, and T45 Labs. The company employs 19 people and focuses on addressing the limitations of conventional drug-coated balloons by using nanotechnology to enhance drug delivery precision and duration, potentially reducing restenosis rates and improving outcomes for patients undergoing coronary interventions.
Business model
Nanotechnology > Nanoenabled Products > Life Science > Drug Delivery,
Cardiac and Vascular Disorders > Medical Devices > Therapeutic Devices > Drug Delivery,
Drug Delivery > Nanoparticle Based
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like Advanced NanoTherapies?
Analyze your pitch deck before your next raise.
Analyze My Deck →